ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 528 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Opinion: ‘UK cancer research could be set back years by COVID-19. We must act now’ June 23, 2020 Adjusting to the Challenges of Life After Cancer: An Expert Perspective May 5, 2022 FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer February 20, 2024 Apalutamide Plus ADT Provides Significant Improvement in Overal Survival and Delays... May 6, 2021 Load more HOT NEWS Low-Pass Genomic Instability Characterisation Assay Identifies Germline Mismatch Repair Deficiency and... The Appraisal – Does a charity have a role in biotech... Answers to Your Questions About the COVID-19 Vaccine A Pet Pug Helped Two Sisters Realize They Both Had Breast...
